Pancreatic β-Cell Failure Mediated by mTORC1 Hyperactivity and Autophagic Impairment
Author(s) -
Alberto Bartolomé,
Maki Kimura-Koyanagi,
Shunichiro Asahara,
Carlos Guillén,
Hiroyuki Inoue,
Kyoko Teruyama,
Shinobu Shimizu,
Ayumi Kanno,
Ana García-Aguilar,
Masato Koike,
Yasuo Uchiyama,
Manuel Benito,
Tetsuo Noda,
Yoshiaki Kido
Publication year - 2014
Publication title -
diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.219
H-Index - 330
eISSN - 1939-327X
pISSN - 0012-1797
DOI - 10.2337/db13-0970
Subject(s) - hyperactivation , mtorc1 , autophagy , mitophagy , microbiology and biotechnology , biology , endoplasmic reticulum , mitochondrion , cell , tsc2 , apoptosis , endocrinology , pi3k/akt/mtor pathway , signal transduction , genetics
Hyperactivation of the mammalian target of rapamycin complex 1 (mTORC1) in β-cells is usually found as a consequence of increased metabolic load. Although it plays an essential role in β-cell compensatory mechanisms, mTORC1 negatively regulates autophagy. Using a mouse model with β-cell-specific deletion of Tsc2 (βTsc2(-/-)) and, consequently, mTORC1 hyperactivation, we focused on the role that chronic mTORC1 hyperactivation might have on β-cell failure. mTORC1 hyperactivation drove an early increase in β-cell mass that later declined, triggering hyperglycemia. Apoptosis and endoplasmic reticulum stress markers were found in islets of older βTsc2(-/-) mice as well as accumulation of p62/SQSTM1 and an impaired autophagic response. Mitochondrial mass was increased in β-cells of βTsc2(-/-) mice, but mitophagy was also impaired under these circumstances. We provide evidence of β-cell autophagy impairment as a link between mTORC1 hyperactivation and mitochondrial dysfunction that probably contributes to β-cell failure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom